期刊
JOURNAL OF PHARMACEUTICAL SCIENCES
卷 93, 期 10, 页码 2448-2457出版社
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.20156
关键词
resveratrol; metabolite; glucuronide; glycosylation; anti-HIV activity
资金
- NIAID NIH HHS [AI 54354] Funding Source: Medline
Resveratrol is a natural product with diverse biological activities. We have previously reported that resveratrol possesses potent synergistic inhibitory activity against human immunodeficiency virus (HIV)-1 infection in combination with nucleoside analogs (Heredia et al. 2000. J Acquir Immune Defic Syndr 25:246-255). As a part of our program in developing resveratrol as a component for anti-HIV chemotherapy, we describe in this article the characterization, chemical synthesis, and biological effects of the human metabolites of resveratrol. We found that resveratrol was metabolized in humans into two metabolites, which were characterized as resveratrol-3-O- and 4'-O-glucuronides. For further biological studies, we reported two simple, alternative methods for the synthesis of the metabolites. The cytotoxic and antiviral activities of resveratrol and its metabolites were compared in cell culture experiments using human peripheral blood mononuclear cells. Whereas resveratrol was cytotoxic at greater than or equal to30 muM, no cytotoxicity was observed for the metabolites at concentrations as high as 300 muM. However, resveratrol showed strong synergistic anti-HIV activity with didanosine at 10 muM, but no synergistic effects were observed for either of the metabolites at up to 300 muM. Nevertheless, the in vitro activity of the metabolites (resveratrol glucuronides) may not necessarily reflect their in vivo function, given the fact that the ubiquitously existing human beta-glucuronidase could convert the metabolites back to resveratrol locally or systematically in vivo. The present studies have implications for future development of resveratrol and/or its derivatives as a chemotherapeutic agent. (C) 2004 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据